5

PRIMARY DOCUMENT

Company: ATOSSA THERAPEUTICS, INC.
Filed: February 14, 2014
Period of Report: December 31, 2013
Accession Number: 0000904454-14-000217

View Document ↗ View on SEC.gov ↗